Study Design. Retrospective single center analysis. Objective. The purpose of our study is to quantify the development of a postoperative radiculitis in our minimally invasive transforaminal lumbar interbody fusion patient population.
The implementation of recombinant human Bone Morphogenic Protein-2 (rhBMP-2) into clinical practice has had a significant impact on modern spinal surgery. Although FDA-approved exclusively for anterior lumbar interbody fusion, BMP has frequently been used in an off-label manner in posterior lumbar fusions and its use has expanded to include both the cervical and thoracic regions of the spine. [1] [2] [3] [4] [5] A multitude of reasons including favorable osteoinductive properties for bone arthrodesis, demonstrated increase in fusion rates, and the obviation of allograft harvest and its associated comorbidities have presumably propelled the use of this biologic agent.
Despite the numerous clinical benefits of rhBMP-2, the adverse effects of rhBMP-2 as evidenced in clinical series has been infrequently reported. Theoretical concerns pertaining to ectopic bone growth, 6 -10 unwanted adjacent level fusion, and the early inflammatory reaction elicited by rhBMP-2 have been published and are discussed elsewhere. [11] [12] However, postoperative lumbar radiculitis associated with rhBMP-2 use has not been previously reported in the literature. We present a series of minimally invasive transforaminal lumbar interbody fusions (TLIF) in which 4 patients incurred a new postoperative lumbar radiculitis that is consistent with the use of rhBMP-2. The goal of this article is to describe the clinical scenario in which this unwanted effect of rh-BMP-2 has been manifested and to elaborate on the clinical presentation, diagnosis, chronology, and postoperative management of this clinical entity.
Methods and Materials
Approval from the Institutional Review Board of Northwestern Memorial Hospital was obtained before the inception of this study. This is a retrospective case cohort study performed at a single institution. All consecutive elective minimally invasive TLIF procedures performed on consenting patients between the ages of 33 and 72 and occurring between September 2005 and March 2008 were included in this review. All surgeries were performed by 1 surgeon (J.K.S.). Indications for surgery included Grade I or II spondylolisthesis, mechanical back pain, or recurrent disc herniation. All cases were electively performed and patients were seen in clinic before their surgical procedure. Patients excluded from the study included nonelective trauma and those with an underlying malignancy. Patients were not randomized and the use of rhBMP-2 was incorporated more frequently into the surgeon's regimen once its beneficial effects were recognized and accepted. A retrospective analysis of all clinic notes, hospital records, operative records, and physician notes was performed. The variables recorded and evaluated are summarized in Table 1 and include the presence of preoperative radiculopathy, new or worsening postoperative radiculitis, and the result of any pertinent imaging that was obtained. Comparisons were then made between the 2 groups.
Patients were grouped into 2 main categories depending on whether rhBMP-2 was used in the surgical procedure. Each patient was positioned prone on a Jackson table with C-arm fluoroscopy used to localize the patient's midline, the lateral entry point at the midtransverse process line, and the disc space of interest. A vertical incision was made at the corresponding levels through the skin and fascia with a scalpel. Serial dilators were placed through the incision to provide exposure. A microscope was used for visualization through the dilators. Soft tissue at the bottom of the tube was removed using Bovie electrocautery to expose the underlying bone of the facet joint. The bone was removed using a high speed burr down to the foramen and level of the disc space. This bone was saved for later bone autografting, using a suction trap. Once adequate decompression and visualization of the exiting and traversing roots were identified, the disc anulus was cut with a scalpel. Using various curettes, rongeurs, pituitary graspers, and shavers, a gross discectomy was performed. Endplate preparation was also carried out using various curettes and shavers, and once adequate endplate preparation was obtained, serial dilators were placed into the disc space until an appropriate cage height was found. For the control group, the bone autograft mixed with bone allograft was impacted into the disc space anteriorly and the cage was filled with the same bone autograft and allograft mixture and impacted into place. For patients receiving rh-BMP-2, INFUSE Bone Graft (Medtronic Spinal and Biologics, Memphis, TN) was placed within each intervertebral space at a volume of 4.2 mg rhBMP-2 per level. The rhBMP-2 was applied to the bovine collagen sponge at a concentration of 1.5 mg/mL and allowed to bind for a minimum of 15 minutes before being implanted. rhBMP-2 (2.1 mg) combined with 4cc of morselized autograft was placed within the interbody device and an additional 2.1 mg of rhBMP-2 was placed anterior to the interbody device with bayoneted forceps. After insertion of the rhBMP-2, the surgical site and disc space was irrigated with a total of 500 mL of bacitracin-saline irrigation. Placement of the graft was confirmed using fluoroscopy. Pedicle screws were then placed percutaneously under fluoroscopy, using a Jamshidi needle to establish an entry point and trajectory into the pedicle. A K-wire was passed down into the pedicle through the Jamshidi needle into the vertebral bodies. Pedicle screws were placed down into the pedicles over the K-wires after appropriate pedicle preparation with taps. Rods were used to stabilize the pedicle screws. This process of placing pedicle screws was performed on the contralateral side. Fluoroscopy was used to examine placement of the screws. The wounds were closed in multiple layers with vicryl sutures and dressed with Dermabond (Ethicon Inc., Somerville, NJ).
Results
The 43 patients studied were comprised of 18 males and 25 females. The mean age was 50.8 years (range, 33-72 years). Overall, there were 35 patients in which rhBMP-2 was used and 8 patients in which rhBMP-2 was not used. No reported instances of new postoperative radicular symptoms without a structural cause were noted in any of the 8 patients in which rhBMP-2 was not used. However, 4 of the 35 patients in which rhBMP-2 was used demonstrated a new onset of radiculitis in the postoperative period with no structural evidence of radicular symptoms. One patient with findings of solely lateral breech of the contralateral pedicle was included in this group. The radiculitis coincided with the side in which the TLIF was performed (i.e., ipsilateral) in all patients. Symptoms included pain along the involved dermatomal distribution and subjective paresthesias in the absence of lower extremity paresis. Computed tomography (CT) imaging of the lumbar spine was used to rule out a structural etiology for the onset of symptoms.
Discussion
The implementation of rhBMP-2 into clinical practice has had a significant impact on modern spinal surgery. rhBMP-2's dedifferentiation effect on mesenchymal cells via an elaborate cascade of molecular events results in the increased production of osteoblasts, ultimately serving to promote osteogenesis and bone healing. 13 In addition to enhancing spinal fusion rates in osteoporotic patients and smokers, it appears that rhBMP-2 has an important role in the treatment of patients with vertebral osteomyelitis. In addition, others have reported larger and more robust fusion masses, lower operative time and intraoperative blood loss, and improved clinical outcomes. 14 -16 As a result of these purported attributes, an expanding body of literature supporting the use of rh-BMP-2 in a variety of clinical settings has emerged. Consequently, a significant amount of "off-label" use has ensued despite the limited spectrum for which rhBMP-2 is FDA-approved. 5, 11, 17 The transient radiculitis we describe pertains to the off-label application of BMP to the TLIF procedure and has not been reported in the approved applications of BMP to on-label applications (ALIF) or in other off-label applications (posterolateral fusion). Lumbar radiculitis associated with the use of rhBMP-2 in lumbar fusions, including TLIFs, has not been previously published in the literature. We are aware of one oral presentation discussed at the 2008 North American Spine Society in which Sanfilippo et al reported on their series of TLIFs with BMP-induced radiculitis. Their data revealed that 9 of 39 (23%) patients developed a postoperative radiculitis with a mean duration of 13.4 months and that 5 of the 9 patients had "on-going" symptoms at the time of the last follow-up. These data, however, were not subjected to peer review at of the time of this manuscript submission. Several pertinent piece of information were not discussed within the abstract; these included how the diagnosis of radiculitis was made, the time of onset of the radiculitis, the dose of rhBMP-2 that was used, their technique of rhBMP-2 insertion, whether or not postoperative radiographic imaging was obtained, and whether there were long-term sequelae that affected clinical outcomes in the respective patient population.
In our series, we noted the occurrence of rhBMP-2-induced radiculitis in 4 of 35 (11%) patients. rhBMP-2 was uniformly used in all of the patients in our series with the exception of the first 8 consecutive patients which preceded the widespread accepted use of rhBMP-2 by the primary surgeon (J.K.S.). Patients comprised in this study included those with Grade I/II spondylolisthesis and degenerative disc disease in which the surgery was described as elective in nature. All trauma, deformity, revision, and neoplasm patients were excluded.
Our diagnosis of rhBMP-2-induced radiculitis was based on several clinical factors. First, the onset of symptoms, namely, 2 to 4 days after surgery, was compatible with the onset of symptoms as seen with other instances of rhBMP-2-induced inflammatory reactions as documented in the literature involving the cervical spine. A traction injury would demonstrate symptoms immediately after the injury. The instances we have ascribed to radiculitis have all been very similar in that the onset was several days after the surgery where the patient, initially, had no characteristic pain. Given that BMP induces an inflammatory response and that this response would take some time to manifest, in addition, the fact that other inflammatory-mediated complications noted in the cervical spine occurred in a similar delayed fashion, it seems implausible that nerve retraction can explain this delayed phenomenon. Second, the complete resolution of this clinical phenomenon was on the order of less than 6 weeks, which again corresponded with the aforementioned patients noted above. Third, the exclusive unilateral nature of the involved radiculitis coupled with the description of a dull, burning ache precisely in the dermatomal distribution of the clinically involved nerve root was again remarkably characteristic. Structural etiologies including medial pedicle screw breech, screw migration, hematoma formation, or a free bone fragment were excluded with thin-cut CT, which was obtained routinely on all patients after surgery. Lastly, the amelioration and ultimate resolution of symptoms with a membrane-stabilizing agent (pregabalin or gabapentin) was also demonstrated consistently.
Stark differences are noted between our series and that of Sanfilippo et al. First, the incidence of radiculitis between the 2 series is significantly different (11% vs. 23%). Second, the duration of symptoms is also markedly different whereas 100% of the patients in our series experienced complete resolution of the radiculitis by week 6 as compared to 100% of the patients experiencing symptoms greater than 6 months (mean: 13.1 month) in the Sanfilippo series. Furthermore, we noted complete resolution of the radiculitis by postoperative week 6 in our series whereas Sanfilippo noted 5 of 9 patients still experiencing "on-going" symptoms at the latest followup. Within the group of patients in which BMP was not used, they still noted 1 patient with symptoms of radiculitis symptoms whereas our series did not have any patient with radiculitis in this group.
Because of the incomplete nature of the data afforded to us in the Sanfilippo et al abstract, our discussion of plausible explanations to account for the differences between clinical results is relegated to pure conjecture. Nevertheless, several factors that may account for their higher incidence of radiculitis include using a higher dose of rhBMP-2, their rhBMP-2 insertion technique and the risk of overpacking the interbody device, not irrigating the surgical area after interbody insertion, structural etiologies including medial pedicle breeches, and overzealous retraction on the nerve root when inserting the cage.
To reiterate, we cannot conclude if or whether any of these issues indeed accounted for the differences in the clinical results and eagerly await more data to further elucidate these matters.
One strength of this study is the selective nature of the patients that were included in this series review. Additionally, having only 1 primary surgeon (J.K.S.) also negated any variability in surgical technique. Limitations of this study include a possible selection bias in rendering the diagnosis of radiculitis given that the clinical criteria used to describe rhBMP-2-induced radiculopathy has not been previously described and thus may be viewed as subjective. We contend that any clinical diagnosis is inherently subjective and the correct diagnosis hinges on the astute observation of the clinical symptoms and their associated characteristics in patients with a risk factor(s) pertaining to the condition to be diagnosed. Another drawback of this study is the small size of the control group. This article could be strengthened by an equivalent number of subjects in each group. However, when reviewing the results and complications of TLIFs in the literature before the widespread use of BMP, the incidence of an immediate postoperative radiculopathy is documented to be from 2% to 7%. 18 -20 Although it can be speculated that the cause of radiculopathy is associated with contusions and the distraction of root structures, especially the root coming out of the foramen used for the approach, the lack of detail to the nature and workup of the symptoms described in these references hinders any insightful comparisons to be drawn. However, this percentage of radiculopathy attributed to manipulation of the nerve root reported in the literature is still less than the 11% incidence of radiculopathy reported in the BMP group from our series. We plan to clarify our correlation with a prospective randomized trial currently approved by the Institutional Review Board. In addition, randomization of rhBMP-2 use would have strengthened group comparisons. Furthermore, randomization would have allowed for more compelling data to demonstrate the absence of radiculitis in the patients that did not receive rhBMP-2 as part of the surgical procedure.
Key Points
• Bone morphogenetic protein causes an acute inflammatory reaction that can theoretically cause a radiculitis.
• We attempt to establish this relationship through our retrospective analysis of 45 minimally invasive TLIF patients.
• We find that there is a 11.4% chance of developing a radiculitis in this patient population.
